LIFECARE AS NOK 040
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue. Lifecare AS was founded in 2006 and is based in Bergen, Norway.
Market Cap & Net Worth: LIFECARE AS NOK 040 (LFC)
LIFECARE AS NOK 040 (F:LFC) has a market capitalization of $16.88 Million (€16.45 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #34638 globally and #4006 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LIFECARE AS NOK 040's stock price €1.10 by its total outstanding shares 15021700 (15.02 Million).
LIFECARE AS NOK 040 Market Cap History: 2021 to 2024
LIFECARE AS NOK 040's market capitalization history from 2021 to 2024. Data shows change from $28.91 Million to $16.88 Million (-26.97% CAGR).
LIFECARE AS NOK 040 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LIFECARE AS NOK 040's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LFC by Market Capitalization
Companies near LIFECARE AS NOK 040 in the global market cap rankings as of March 19, 2026.
Key companies related to LIFECARE AS NOK 040 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
LIFECARE AS NOK 040 Historical Marketcap From 2021 to 2024
Between 2021 and today, LIFECARE AS NOK 040's market cap moved from $28.91 Million to $ 16.88 Million, with a yearly change of -26.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €16.88 Million | -74.79% |
| 2023 | €66.98 Million | +127.06% |
| 2022 | €29.50 Million | +2.04% |
| 2021 | €28.91 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 27th, 2025 the market cap of LIFECARE AS NOK 040 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.88 Million USD |
| MoneyControl | $16.88 Million USD |
| MarketWatch | $16.88 Million USD |
| marketcap.company | $16.88 Million USD |
| Reuters | $16.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.